RU2015139946A - New eye drops for conservative treatment and prevention of age-related nuclear cataracts - Google Patents

New eye drops for conservative treatment and prevention of age-related nuclear cataracts Download PDF

Info

Publication number
RU2015139946A
RU2015139946A RU2015139946A RU2015139946A RU2015139946A RU 2015139946 A RU2015139946 A RU 2015139946A RU 2015139946 A RU2015139946 A RU 2015139946A RU 2015139946 A RU2015139946 A RU 2015139946A RU 2015139946 A RU2015139946 A RU 2015139946A
Authority
RU
Russia
Prior art keywords
age
prevention
eye drops
conservative treatment
new eye
Prior art date
Application number
RU2015139946A
Other languages
Russian (ru)
Other versions
RU2637875C2 (en
Inventor
Надежда Витальевна Корсакова
Original Assignee
Надежда Витальевна Корсакова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Надежда Витальевна Корсакова filed Critical Надежда Витальевна Корсакова
Priority to RU2015139946A priority Critical patent/RU2637875C2/en
Publication of RU2015139946A publication Critical patent/RU2015139946A/en
Application granted granted Critical
Publication of RU2637875C2 publication Critical patent/RU2637875C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Claims (1)

Глазные капли для профилактики и лечения возрастной катаракты ядерного вида, отличающиеся тем, что в качестве активного антикатарактального компонента применяют антагонист серотониновых рецепторов (ондансетрона гидрохлорида дигидрат) в виде раствора при следующем соотношении: ондансетрона гидрохлорида дигидрат - 0,002-0,2 мг; вода для инъекций - 1,0 мл.Eye drops for the prevention and treatment of age-related cataracts of a nuclear type, characterized in that an antagonist of serotonin receptors (ondansetron hydrochloride dihydrate) is used as an active anti-cataract component in the form of a solution in the following ratio: ondansetron hydrochloride dihydrate - 0.002-0.2 mg; water for injection - 1.0 ml.
RU2015139946A 2015-09-21 2015-09-21 New eye droplets for conservative treatment and prevention of the age-related nuclear cataract RU2637875C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015139946A RU2637875C2 (en) 2015-09-21 2015-09-21 New eye droplets for conservative treatment and prevention of the age-related nuclear cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015139946A RU2637875C2 (en) 2015-09-21 2015-09-21 New eye droplets for conservative treatment and prevention of the age-related nuclear cataract

Publications (2)

Publication Number Publication Date
RU2015139946A true RU2015139946A (en) 2017-03-24
RU2637875C2 RU2637875C2 (en) 2017-12-07

Family

ID=58454714

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015139946A RU2637875C2 (en) 2015-09-21 2015-09-21 New eye droplets for conservative treatment and prevention of the age-related nuclear cataract

Country Status (1)

Country Link
RU (1) RU2637875C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2720676C2 (en) * 2019-07-22 2020-05-12 Надежда Витальевна Корсакова Eye drops for treating age-related nuclear cataract
RU2748598C1 (en) * 2020-09-15 2021-05-27 Надежда Витальевна Корсакова Improved eye drops for prevention and treatment of early manifestations of age-related nuclear cataract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1899304A (en) * 2006-07-07 2007-01-24 中国科学院南海海洋研究所 Eye drops for cataract and its preparing method
RU2411926C2 (en) * 2009-01-13 2011-02-20 Надежда Витальевна Корсакова Method of conservative treatment and prevention of nuclear type of age cataract
RU2404768C1 (en) * 2009-10-28 2010-11-27 Федеральное агентство по науке и инновациям Eye drops
RU2485939C1 (en) * 2012-06-19 2013-06-27 Станислав Анатольевич Кедик Disulfiram and taurine-containing ophthalmological medication in form of eye drops

Also Published As

Publication number Publication date
RU2637875C2 (en) 2017-12-07

Similar Documents

Publication Publication Date Title
EA201791256A1 (en) HINAZOLIN DERIVATIVES USED FOR HIV TREATMENT
EA201792536A1 (en) TRIAZOLE AGONISTS APJ RECEPTOR
EA201790306A1 (en) 2- (MORFOLIN-4-IL) -1,7-NAFTYRIDINES
PH12018501903A1 (en) Methods of treating depression using orexin-2 receptor antagonists
EA201691070A1 (en) NEW TRICYCLIC CONNECTIONS AS ANTICATIVE AGENTS
MX2016016593A (en) Novel aminoalkyl benzothiazepine derivative and use thereof.
EA201791019A1 (en) POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS
EA201791304A1 (en) IZOHINOLINA DERIVATIVES FOR HIV TREATMENT
PH12017501424B1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
EA201590873A1 (en) Compounds possessing the activity of antagonists of muscarinic receptors and agonists of beta2 adrenergic receptors
MX2017006709A (en) Agent for preventing or improving symptoms caused by imbalance of sex hormones.
EA201891782A1 (en) HETEROCYCLIC SULPHONAMIDE DERIVATIVE AND CONTAINING HER MEDICINE
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
EA201791480A1 (en) NEW BENZIMIDAZOLE DERIVATIVES AS ANTIHARMONAL AGENTS
RU2015139946A (en) New eye drops for conservative treatment and prevention of age-related nuclear cataracts
EA201890896A1 (en) SOLID PREPARATION FOR ORAL APPLICATION CONTAINING AMORPHOUS SOLIPHENACIN, AND A METHOD FOR ITS OBTAINING
EA201892529A1 (en) COMBINATION OF PURE ANTAGONISTS OF 5-HTRECEPTORS WITH ACETYLHOLINESTERASE INHIBITORS
EA201892837A1 (en) PHYSIOLOGICALLY BALANCED COMPOUNDS FOR INJECTIONS, INCLUDING PHOSNET SUPPORTANT
MX2017015047A (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity.
EA201892583A1 (en) COMBINATION OF PURE ANTAGONISTS OF A 5-HT RECEPTOR WITH AN ANTAGONIST OF NMDA RECEPTOR
RU2009100649A (en) METHOD FOR CONSERVATIVE TREATMENT AND PREVENTION OF NUCLEAR KIND OF AGE CATARACT
EA201501130A1 (en) OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION
WO2015181837A3 (en) Novel compounds as anti-tubercular agents
EA201691489A1 (en) NEW HETEROCYCLIC COMPOUNDS AS KAPPA-OPIODI AGONISTS
PH12017501214A1 (en) Cgrp antagonist peptides

Legal Events

Date Code Title Description
TC4A Change in inventorship

Effective date: 20200729

PD4A Correction of name of patent owner
QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20200803

Effective date: 20200803

QZ41 Official registration of changes to a registered agreement (patent)

Free format text: LICENCE FORMERLY AGREED ON 20200803

Effective date: 20201126